Fundz

Alithea Genomics secures CHF 6.9M Seed Round, led by Genku Ventures to enhance RNA-seq for drug screening and toxicology.

PRIVATEMar 04, 2026

Amount Raised

CHF6.9 Million

Round Type

Seed

LausanneManufacturingBiotechnologyHealth Care

Investors

Novalis BiotechZürcher KantonalbankGenku Ventures

Description

Alithea Genomics has closed a CHF 6.9 million Seed Round, with an additional CHF 3 million led by Genku Ventures. The funding aims to accelerate commercialization of its MERCURIUSTM DRUG-seq kits for drug screening and toxicology. This investment will also support new technology development and proprietary data assets. Frederik Decouttere has been appointed as CEO.

Quick answer

Alithea Genomics raised CHF6.9 Million in a Seed round, dated March 4, 2026. Investors: Novalis Biotech, Zürcher Kantonalbank and Genku Ventures. Alithea Genomics is based in Lausanne, Vaud, Switzerland.

How much did Alithea Genomics raise?
Alithea Genomics raised CHF6.9 Million in a Seed round on March 4, 2026.
Who invested in Alithea Genomics?
Novalis Biotech, Zürcher Kantonalbank and Genku Ventures are named as investors in this round.
What does Alithea Genomics do?
Alithea Genomics is a Switzerland-based startup specializing in manufacturing ribonucleic acid (RNA) sequencing products to study gene expressions of cells, with a focus on cancer research.
Where is Alithea Genomics based and how big is it?
Alithea Genomics is based in Lausanne, Vaud, Switzerland.
Who are the decision-makers at Alithea Genomics?
Fundz holds 1 contact at Alithea Genomics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as Alithea Genomics that raised within 45 days of this round, from Fundz verified event records.

  • Harvard Apparatus Regenerative Technology raised $300K (Debt Financing) on April 15, 2026.
  • Route 92 Medical raised $50M (Funding Round) on April 7, 2026.
  • PanTera raised $4M on March 31, 2026.
  • Cellbricks Therapeutics raised $8.1M (Seed) on March 26, 2026.
  • Elmed Life Sciences raised $2.7M (Seed) on March 26, 2026.
  • IceCure Medical raised $4M on March 26, 2026.

Who to call at Alithea Genomics, and when

A new round usually means Alithea Genomics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Alithea Genomics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Alithea Genomics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Alithea Genomics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Alithea Genomics

Location

Lausanne, Vaud, Switzerland

About

Alithea Genomics is a Switzerland-based startup specializing in manufacturing ribonucleic acid (RNA) sequencing products to study gene expressions of cells, with a focus on cancer research.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Alithea Genomics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Alithea Genomics's next move

See what Strategic adds

Alithea Genomics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.